INDV:NASDAQIndivior Pharmaceuticals, Inc. Analysis
Data as of 2026-04-10 - not real-time
$31.68
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Indivior Pharmaceuticals (INDV) trades at $31.68, notably below its DCF fair value of $52.68, suggesting roughly 48% upside potential. The company posted 19.7% revenue growth with an impressive 84% gross margin and 37% operating margin, while free cash flow remains positive at $221.8 M. Forward EPS of $3.44 versus trailing $1.64 drives a forward P/E of 9.2, well under the industry average.
Technically, the stock sits above its 20‑day SMA ($30.42) and shows a bullish MACD histogram (+0.374) despite a neutral RSI (53). Support near $27.68 and decreasing volume signal caution, but the recent upsized $450 M convertible senior notes provide financing for pipeline candidates without straining cash reserves.
Technically, the stock sits above its 20‑day SMA ($30.42) and shows a bullish MACD histogram (+0.374) despite a neutral RSI (53). Support near $27.68 and decreasing volume signal caution, but the recent upsized $450 M convertible senior notes provide financing for pipeline candidates without straining cash reserves.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover with positive histogram
- Price above 20‑day SMA providing short‑term momentum
- Support level at $27.68 limiting downside risk
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth (19.7%) and high operating margins
- Forward EPS upside and low forward P/E (~9)
- Capital raise via $450 M convertible notes to fund pipeline expansion
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Significant valuation gap vs DCF fair value (~48% upside)
- Robust product pipeline (INDV‑2000, INDV‑6001) targeting opioid use disorder
- Undervalued relative to industry PE and resilient cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth19.70%
Profit Margin16.95%
P/E Ratio19.3
ROA19.22%
P/B Ratio-40.4
Op. Cash Flow$-27000000
Free Cash Flow$221.8M
Industry P/E26.1
Technical Analysis
TrendNeutral
RSI53.5
Support$27.68
Resistance$32.76
MA 20$30.42
MA 50$32.28
MA 200$27.91
MACDBullish
VolumeDecreasing
Fear & Greed Index86.79
Valuation
Fair Value$52.68
Target Price$46.86
Upside/Downside47.91%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.80
Volatility43.44%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.